Biocon will market Liraglutide under two brand names - Liraglutide Biocon for diabetes, which is a generic version of Victoza ...

If you’re a Queer Eye fan, then you know and love Jonathan Van Ness, the show’s bubbly hairstylist known to share their words ...

Biotechnology firm Biocon on Friday said it has launched a product for diabetes and obesity management in the UK.

Biotechnology firm Biocon on Friday said it has launched a product for diabetes and obesity management in the UK.

Embecta's compelling ~44% free cash flow yield offers a strong risk-reward despite headwinds from new insulin technologies ...

This launch follows the nod from the U.K.'s Medicines and Healthcare Products Regulatory Agency (MHRA), making Biocon the ...

Sara Burnett, executive director of non-profit ReFED, on food waste in the US, government policies, and the impact of AI and ...

Biocon announced the launch of its GLP-1 peptide, Liraglutide, for diabetes and obesity, in the United Kingdom (U.K.). The drug-device combination will be marketed in the U.K. under the brand names ...

Companies such as PepsiCo and Mondelēz haven’t seen an impact on business, while Healthy Choice maker Conagra sees the ...

Ahead of World Obesity Day, we examine the impact of the game-changing drugs that control appetite. Increasingly being taken ...

Investors seem to be questioning long-term demand trends in alcohol. This may have sent the valuation of Wide Moat spirits ...

Lorrie & Rae show how to turn their Dessert Mixologist mix into a quick, delicious cake using water, oil, and your favorite ...